SWKS News Alert Skyworks Solutions (SWKS) 60.71 11/13/2014 1

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Skyworks Solutions (SWKS) 60.71 $SWKS

Intel Mobile Unit Loss Forecast At $4 Billion
at Investor's Business Daily - 2 hrs 43 mins ago
Intel's (INTC) Mobile and Communications Group will lose $4 billion in 2014, forecasts Morgan Stanley, which says bullish views on the chipmaker overestimate the unit's ability to break-even in the near future. Morgan Stanley analyst Joseph Moore...
SWKS: 60.71 (-0.28), BRCM: 41.79 (+0.64), TXN: 51.18 (-0.10), ARMH: 41.26 (-0.13), QCOM: 70.65 (+0.36), INTC: 33.68 (+0.30), AAPL: 112.82 (+1.57)

Earnings Estimates Moving Higher Skyworks Solutions (SWKS): Time to Buy? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 7:54AM CST
Skyworks Solutions has decent short-term momentum and is also seeing solid activity on the earnings estimate revision front for the coming quarter and year.
SWKS: 60.71 (-0.28)

Shares of SWKS Up 13.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Nov 12, 5:12PM CST
SmarTrend identified an Uptrend for Skyworks Solutions (NASDAQ:SWKS) on October 21st, 2014 at $53.86. In approximately 3 weeks, Skyworks Solutions has returned 13.25% as of today's recent price of $60.99.
SWKS: 60.71 (-0.28)

Skyworks Unveils New $300 Million Stock Buyback Program - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 12:10PM CST
Skyworks Solutions (SWKS) unveiled a new stock repurchase program under which it plans to buy back up to $300 million of its common stock.
GE: 26.42 (-0.10), SWKS: 60.71 (-0.28), GM: 31.65 (+0.23), COL: 84.81 (-0.42)

Time to Focus on Skyworks Solutions (SWKS) for Strong Earnings Growth Potential - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 7:43AM CST
Skyworks Solutions is one such company that might be well-positioned for future earnings growth as this firm, which is in technology sector, saw EPS growth of 52.5% last year, and is looking great for this year too.
SWKS: 60.71 (-0.28)

TowerJazz Remains On Track And Undervalued
Jaret Wilson - Seeking Alpha - Wed Nov 12, 4:50AM CST
On August 26th, I discussed a number of factors that have left TowerJazz (NASDAQ: TSEM ) extremely underpriced, including a joint venture with Panasonic, cost cutting measures, strong business conditions, operational leverage, and more. Since then...
SWKS: 60.71 (-0.28), IBM: 162.79 (+0.87), MCHP: 42.89 (-0.49), TSEM: 11.04 (+0.62), HIMX: 7.10 (-0.12), RFMD: 13.33 (+0.08)

Skyworks: The Explosive Growth Catalyst Management Can't Talk About
Lou Basenese - at Seeking Alpha - Tue Nov 11, 8:06PM CST

RESN: 7.19 (+0.16), SWKS: 60.71 (-0.28)

SKYWORKS
at Investor's Business Daily - Tue Nov 11, 5:30PM CST
SKYWORKS (SWKS) will buy back up to $300 mil in stock over 2 years. The chipmaker's stock rose 1%.
SWKS: 60.71 (-0.28)

Skyworks launches $300M buyback
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 4:11PM CST

SWKS: 60.71 (-0.28)

Skyworks Announces New $300 Million Stock Repurchase Program
Business Wire - Tue Nov 11, 3:30PM CST
Skyworks Solutions, Inc. (NASDAQ: SWKS) an innovator of high performance analog semiconductors enabling a broad range of end markets, today announced that its Board of Directors has authorized the repurchase of up to $300 million of the company's common stock from time to time prior to November 11, 2016, on the open market or in privately negotiated transactions, in compliance with applicable securities laws and other legal requirements. This newly authorized stock repurchase program replaces in its entirety the $250 million stock repurchase program which was approved by the Board of Directors on July 16, 2013, and had $63.9 million of repurchase authority remaining.
SWKS: 60.71 (-0.28)

Skyworks Upgraded to Strong Buy on Healthy Q4 Results - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 2:20PM CST
On Nov 11, Zacks Investment Research upgraded analog semiconductor manufacturer Skyworks Solutions Inc. (SWKS) to a Zacks Rank #1 (Strong Buy) from a Zacks Rank #2 (Buy).
ASX: 6.02 (unch), SWKS: 60.71 (-0.28), ANAD: 0.86 (+0.07), FORM: 8.43 (-0.26)

Bulls Rule As Volatility Recedes And Investors Position For Holiday Cheer
Scott Martindale - Seeking Alpha - Mon Nov 10, 9:10AM CST
After displaying a classic V-bottom reversal to what turned out to be a quick and anemic attempt by the bears to bring about a real correction, bullish fervor is becoming contagious, especially as the traditionally strong holiday season approaches....
ACT: 241.63 (+1.01), LUV: 39.46 (+0.09), IYZ: 30.60 (+0.05), SPY: 204.19 (+0.23), IDU: 113.28 (-1.06), AMAT: 22.62 (+0.13), JAZZ: 172.98 (-0.55), IYW: 103.42 (+0.53), FDX: 171.57 (-0.23), IYK: 104.25 (+0.13), IYJ: 106.29 (-0.37), XTN: 102.96 (-0.04), IYH: 142.41 (-0.21), LSTR: 76.51 (-0.56), SWKS: 60.71 (-0.28), IYM: 84.81 (-0.13), IYC: 130.57 (+0.91), NXPI: 72.58 (-0.82), SOXX: 87.11 (+0.01), IYF: 88.02 (-0.20), IYE: 48.34 (-0.67), ADM: 50.81 (+0.10), ARRS: 28.43 (+0.02), PJP: 66.99 (-0.21), ALXN: 193.59 (-0.10)

Semiconductor Momentum Is Slowing, So Book Profits in Intel, Micron Tech
at The Street - Mon Nov 10, 8:34AM CST
The PHLX Semiconductor Index has become extremely volatile in the second half of 2014, and the recent rebound provides an opportunity to book profits.
MU: 32.94 (+0.03), SWKS: 60.71 (-0.28), QQQ: 102.90 (+0.44), LRCX: 78.85 (-0.12), INTC: 33.68 (+0.30), AAPL: 112.82 (+1.57), AVGO: 87.44 (+0.39)

Cramer's Lightning Round - Let's Buy Skyworks (11/7/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Sun Nov 09, 9:59AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Friday November 7. Bullish Calls: Skyworks Solutions (NASDAQ: SWKS ): "Why don't we buy Skyworks Solutions? I like the proprietary nature of it."...
MU: 32.94 (+0.03), LMT: 187.97 (+1.10), SWKS: 60.71 (-0.28), OPK: 8.34 (-0.03), AVAV: 29.81 (+0.04), QCOM: 70.65 (+0.36), TXN: 51.18 (-0.10), BPL: 79.15 (-0.31), SDRL: 20.65 (-0.62)

Facebook, Skyworks Among IBD 50's Top 5 Tech Earnings
at Investor's Business Daily - Sat Nov 08, 7:02AM CST
With earnings season starting to wind down, companies that reported excellent quarterly earnings growth, such as Faceboook, are likely candidates for a stock watch list. Today's IBD 50 list features five tech stocks that posted superior earnings...
GPRO: 76.47 (-0.38), GE: 26.42 (-0.10), EBAY: 54.37 (+0.31), SWKS: 60.71 (-0.28), ARRS: 28.43 (+0.02), FB: 74.25 (-0.47), GM: 31.65 (+0.23), TSM: 22.34 (+0.29), GOOGL: 556.44 (-1.81), NXPI: 72.58 (-0.82), INTC: 33.68 (+0.30), COL: 84.81 (-0.42), AAPL: 112.82 (+1.57)

'Mad Money' Lightning Round: I'm Going Nowhere Near Sony
at The Street - Sat Nov 08, 5:00AM CST
Cramer likes Skyworks Solutions over Micron, Kinder Morgan over Buckeye Partners and thinks SeaDrill is a house of pain.
KMI: 38.38 (-0.15), MU: 32.94 (+0.03), LMT: 187.97 (+1.10), SWKS: 60.71 (-0.28), OPK: 8.34 (-0.03), TXN: 51.18 (-0.10), QCOM: 70.65 (+0.36), BPL: 79.15 (-0.31), AVAV: 29.81 (+0.04), IRM: 38.37 (+0.32), SNE: 20.41 (-0.22), SDRL: 20.65 (-0.62)

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Nov 07, 7:19PM CST
Next week Cramer will be watching earnings from WhiteWave Foods, DR Horton and Wal-Mart, among many others.
DHI: 24.29 (+0.28), KMI: 38.38 (-0.15), HK: 3.04 (-0.01), KSS: 56.07 (-1.84), GE: 26.42 (-0.10), LMT: 187.97 (+1.10), AVAV: 29.81 (+0.04), WMT: 82.94 (+3.74), SNE: 20.41 (-0.22), M: 61.57 (unch), SDRL: 20.65 (-0.62), T: 35.61 (+0.21), W: 22.01 (+0.70), OPK: 8.34 (-0.03), QCOM: 70.65 (+0.36), TWTR: 40.04 (-2.50), EPR: 56.73 (+0.14), AAPL: 112.82 (+1.57), HSIC: 130.28 (+0.60), CSCO: 25.68 (+0.57), WFM: 46.72 (-0.76), CY: 9.98 (-0.16), MU: 32.94 (+0.03), SWKS: 60.71 (-0.28), IRM: 38.37 (+0.32), BAC: 17.22 (-0.07), MO: 49.45 (+0.12), CSX: 36.63 (-0.14), WWAV: 36.14 (+0.10), GILD: 104.20 (-2.70), TXN: 51.18 (-0.10), BPL: 79.15 (-0.31), JCP: 7.10 (-0.66), JWN: 73.25 (+0.40), BABA: 114.84 (-3.36)

Ride The Smart-Money Coattails: Use IBD's Funds Pages
at Investor's Business Daily - Fri Nov 07, 3:10PM CST
Selecting stocks that have superior profit and sales growth is not the sole key to success in the market. Neither is simply buying stocks with outstanding price strength. Before you invest in a stock, make sure that it also is a favorite among the...
AGN: 196.21 (-0.30), HCA: 64.77 (-0.07), BIDU: 244.09 (-5.73), ZBRA: 70.61 (-1.32), SWKS: 60.71 (-0.28), ALK: 56.24 (+0.07), CELG: 107.43 (-0.82)

Skyworks slumps post-earnings; RFMD, TQNT, AVGO also off
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 2:18PM CST

SWKS: 60.71 (-0.28), TQNT: 22.17 (+0.07), AVGO: 87.44 (+0.39), RFMD: 13.33 (+0.08)

Skyworks Price Targets Up On Q4 Beat, Q1 Guidance
at Investor's Business Daily - Fri Nov 07, 11:40AM CST
Skyworks Solutions (SWKS) on Friday received six price target increases from analysts after the radio-frequency chipmaker's fiscal Q4 earnings report late Thursday easily topped Wall Street views. The Woburn, Mass.-based company's outlook for the...
GE: 26.42 (-0.10), SWKS: 60.71 (-0.28), TQNT: 22.17 (+0.07), GM: 31.65 (+0.23), COL: 84.81 (-0.42), AAPL: 112.82 (+1.57), RFMD: 13.33 (+0.08)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 79

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 421

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 72

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 140

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 93

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 312

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 87

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading

Top 5 Most Recently Viewed Articles

Nippon Express Europe Partners with Formag for Logistics Support

Updated Category News Views 213

Nippon Express Europe and Formag Form New Logistics Partnership Nippon Express Europe GmbH, part of NIPPON EXPRESS HOLDINGS, INC., has recently signed a cooperation agreement with Ukrainian logistics provider, Formag-Kiev. This significant collaboration aims to provide essential logistical support for the reconstruction of Ukraine. Commitment to Ukrainian Reconstruction...

Continue Reading
Escalating Legal Action Over LIBRA Token Sparks Controversy

Updated Category News Views 265

Legal Developments in the LIBRA Token Case A prominent Argentine lawyer has made headlines by calling for global law enforcement to apprehend a cryptocurrency figure involved in the LIBRA token controversy. Details of the Extradition Request Gregorio Dalbon, known for his defense work with former Argentine President Cristina Fernandez in a prominent corruption matter, has...

Continue Reading
Tesla Prevails in Motion to Dismiss Racial Bias Lawsuit

Updated Category News Views 230

Tesla's Legal Victory Against Racial Bias Allegations Under the direction of Elon Musk, Tesla Inc. (NASDAQ: TSLA) has successfully overturned a significant class action lawsuit that was brought forth by more than 6,000 African American workers. These workers alleged racial discrimination at Tesla's Fremont assembly plant. This ruling is a key moment in the ongoing...

Continue Reading
ZenaTech Unveils Specialized AI Hub to Bolster US Defense Tactics

Updated Category News Views 100

ZenaTech Launches Innovative AI Development Center Vancouver, British Columbia – ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) has taken a significant stride toward advancing artificial intelligence technologies by establishing Zena AI, Inc. This new AI Development Center will focus on crafting specialized AI solutions tailored for defense and homeland security...

Continue Reading
Investors Reminded of Action Timeline Against ICON plc - ICLR

Updated Category News Views 172

Understanding the Legal Proceedings Against ICON plc In an important reminder for shareholders, Kahn Swick & Foti, LLC is emphasizing the critical timeline for investors affected by losses from their holdings in ICON plc (NASDAQ: ICLR). The firm, led by former Louisiana Attorney General Charles C. Foti, Jr., is urging investors who incurred losses exceeding $100,000 to...

Continue Reading